𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Retinol and α-Tocopherol in Morbid Obesity and Nonalcoholic Fatty Liver Disease

✍ Scribed by José I. Botella-Carretero; José A. Balsa; Clotilde Vázquez; Roberto Peromingo; Manuela Díaz-Enriquez; Héctor F. Escobar-Morreale


Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
160 KB
Volume
20
Category
Article
ISSN
0960-8923

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Morbid obesity, nonalcoholic fatty liver
✍ Savita Srivastava; Zobair M. Younossi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Objective: This study examines the impact of biliopancreatic diversion, a malabsorptive variant of gastric bypass, on liver histology. ## Methods: Liver samples were collected from 689 severely obese (bmi 47 +/- 9 kg m(2)) patients undergoing biliopancreatic diversion. exclusion criteria inclu

Hepatic Free Fatty Acids in Alcoholic Li
✍ Peter G. Mavrelis; Helmut V. Ammon; John J. Gleysteen; Richard A. Komorowski; Ur 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

Alcoholic liver disease is characterized by the accumulation of fat and inflammatory changes in the liver. Because free fatty acids, the precursors of triglycerides, can damage biological membranes, accumulation of free fatty acids in the liver might be in part responsible for the functional and mor

Obesity and nonalcoholic fatty liver dis
✍ Elisa Fabbrini; Shelby Sullivan; Samuel Klein 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 639 KB

Obesity is associated with an increased risk of nonalcoholic fatty liver disease (NAFLD). Steatosis, the hallmark feature of NAFLD, occurs when the rate of hepatic fatty acid uptake from plasma and de novo fatty acid synthesis is greater than the rate of fatty acid oxidation and export (as triglycer

Reduced cardio-respiratory fitness in ob
✍ Melania Manco; Valerio Nobili 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 1 views

Serum or plasma samples? The "Cinderella" role of blood collection procedures: Preanayltical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation. Arterioscler Thr